- Home
- SYBX vs PMD Comparison
SYBX vs PMD Comparison
Compare SYBX & PMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- PMD
- Stock Information
- Founded
- SYBX N/A
- PMD 1986
- Country
- SYBX United States
- PMD United States
- Employees
- SYBX N/A
- PMD N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- PMD Medical Specialities
- Sector
- SYBX Health Care
- PMD Health Care
- Exchange
- SYBX Nasdaq
- PMD Nasdaq
- Market Cap
- SYBX 15.9M
- PMD 13.7M
- IPO Year
- SYBX N/A
- PMD N/A
- Fundamental
- Price
- SYBX $1.43
- PMD $2.34
- Analyst Decision
- SYBX Buy
- PMD
- Analyst Count
- SYBX 4
- PMD 0
- Target Price
- SYBX $15.50
- PMD N/A
- AVG Volume (30 Days)
- SYBX 11.4K
- PMD 26.2K
- Earning Date
- SYBX 11-12-2024
- PMD 11-12-2024
- Dividend Yield
- SYBX N/A
- PMD N/A
- EPS Growth
- SYBX N/A
- PMD N/A
- EPS
- SYBX N/A
- PMD N/A
- Revenue
- SYBX $2,777,000.00
- PMD $20,258,000.00
- Revenue This Year
- SYBX N/A
- PMD N/A
- Revenue Next Year
- SYBX N/A
- PMD N/A
- P/E Ratio
- SYBX N/A
- PMD N/A
- Revenue Growth
- SYBX 292.23
- PMD N/A
- 52 Week Low
- SYBX $1.22
- PMD $1.63
- 52 Week High
- SYBX $5.12
- PMD $3.93
- Technical
- Relative Strength Index (RSI)
- SYBX 50.79
- PMD 51.58
- Support Level
- SYBX $1.37
- PMD $2.31
- Resistance Level
- SYBX $1.45
- PMD $2.35
- Average True Range (ATR)
- SYBX 0.07
- PMD 0.02
- MACD
- SYBX 0.00
- PMD -0.00
- Stochastic Oscillator
- SYBX 31.82
- PMD 37.50
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About PMD Psychemedics Corporation
Psychemedics Corp is engaged in providing testing services for the detection of drugs of abuse through the analysis of hair samples. The company operates through a single segment of drug testing services which include training for the collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit testing of samples. The testing methods of the company utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. They provide testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples. Geographically it generates the majority of its revenue from the United States.